Načítá se...
Involvement of Patient Organisations in Research and Development of Orphan Drugs for Rare Diseases in Europe
Patients’ representatives have an increasingly present voice in all aspects of drug development from fundamental research through regulatory processes to health technology assessment. Although major advances have been made in raising awareness and increasing funding for rare diseases, important chal...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
S. Karger AG
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3531929/ https://ncbi.nlm.nih.gov/pubmed/23293582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000342758 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|